MONTIOLI, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 1.966
EU - Europa 1.738
AS - Asia 763
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AF - Africa 1
Totale 4.484
Nazione #
US - Stati Uniti d'America 1.945
GB - Regno Unito 726
CN - Cina 707
IT - Italia 264
SE - Svezia 171
IE - Irlanda 139
FR - Francia 137
DE - Germania 105
FI - Finlandia 102
UA - Ucraina 39
BE - Belgio 20
CA - Canada 19
KR - Corea 18
VN - Vietnam 18
RU - Federazione Russa 11
JP - Giappone 7
AU - Australia 5
ES - Italia 4
NL - Olanda 4
AT - Austria 3
CL - Cile 3
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
GR - Grecia 2
HK - Hong Kong 2
IN - India 2
IQ - Iraq 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
Totale 4.484
Città #
Southend 665
Chandler 384
Jacksonville 255
Ann Arbor 206
Woodbridge 172
Dublin 139
Verona 127
Beijing 126
Houston 119
Jinan 86
Ashburn 77
Shenyang 75
Wilmington 70
Nanjing 63
Lawrence 58
Princeton 58
New York 55
Redmond 43
Hebei 39
Ningbo 33
Tianjin 29
Changsha 28
Helsinki 27
Seattle 24
Nanchang 23
Haikou 22
Zhengzhou 22
Falls Church 20
Lanzhou 20
Brussels 19
Hangzhou 18
Redwood City 17
Seoul 17
Taiyuan 16
Lancaster 13
Taizhou 13
Dong Ket 12
Jiaxing 12
Guangzhou 11
Milan 11
Sindelfingen 11
Boardman 10
Fuzhou 9
Toronto 9
Dearborn 8
Elora 8
Norwalk 7
Parma 6
Rome 6
San Francisco 6
Kemerovo 5
Los Angeles 5
Perugia 5
Auburn Hills 4
Cagliari 4
Fairfield 4
Tokyo 4
Chicago 3
Detroit 3
Dongguan 3
London 3
Madrid 3
Padova 3
Pieve di Soligo 3
Qingdao 3
Sydney 3
Washington 3
Xiangfen 3
Boston 2
Cambridge 2
Chions 2
Clearwater 2
Glasgow 2
Kirrweiler 2
Lappeenranta 2
Las Vegas 2
Mainz 2
Martignacco 2
Montreal 2
Nashville 2
Nürnberg 2
Orzinuovi 2
Piacenza 2
Rubano 2
San Diego 2
Sofia 2
Tappahannock 2
Torviscosa 2
Vienna 2
Amsterdam 1
Aprilia 1
Augusta 1
Aversa 1
Azzano Decimo 1
Bangkok 1
Berlin 1
Boydton 1
Brescia 1
Büdelsdorf 1
Canberra 1
Totale 3.421
Nome #
Analisi cinetiche, spettrofotometriche e mutazionali di due enzimi PLP-dipendenti del fold type I. Meccanismi catalitici, processi di folding e dimerizzazione 205
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 135
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 132
Holo-and apocystalysin from Treponema denticola: two different conformations 126
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 120
The novel R347g pathogenic mutation Of aromatic amino acid decarboxylase provides additional molecular insights into enzyme catalysis and deficiency 111
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 103
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 97
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 96
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 93
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 92
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 91
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 89
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 89
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 86
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 85
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 85
Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis 85
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 84
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 83
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 82
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 82
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 82
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 81
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 81
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 79
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 77
Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T 77
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 76
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 75
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 74
Extensive deamidation of RNase A inhibits its oligomerization through 3D domain swapping 74
Pathogenic variants of human Aromatic L-Amino Acid Decarboxylase: evidences of misfolding in functionally active variants 73
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 72
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 70
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 69
New variants of AADC deficiency expand the knowledge of enzymatic phenotypes 68
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 66
Oligomeric state and thermal stability of apo- and holo- human ornithine δ-aminotransferase 66
Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5'-Phosphate Histidine Decarboxylase 66
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 64
Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations 64
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 62
Properties of RNase A monomer and dimers depend on the oligomerization pathway followed. 62
Parkinson's Disease: recent updates in the identification of human dopa decarboxylase inhibitors 60
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook 60
Molecular insights into primary hyperoxaluria Type I pathogenesis. 59
Aromatic amino acid decarboxylase deficiency: the added value of biochemistry 58
Deciphering the fate of slan+ -monocytes in human tonsils by gene expression profiling 56
RNase A domain-swapped dimers produced through different methods: structure–catalytic properties and antitumor activity 56
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 54
Compound heterozygosis in AADC deficiency: A complex phenotype dissected through comparison among heterodimeric and homodimeric AADC proteins 54
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 53
Molecular and cellular studies reveal folding defects of human ornithine aminotransferase variants associated with gyrate atrophy of the choroid and retina 51
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-RAY and NMR studies provide insight into its catalytic features 48
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 42
Dimerization of human angiogenin and of variants involved in neurodegenerative diseases 38
A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies 30
Biochemical and bioinformatic studies of mutations of residues at the monomer-monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina 10
Human RNase 1 can extensively oligomerize through 3D domain swapping thanks to the crucial contribution of its C-terminus 9
Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations 8
Totale 4.575
Categoria #
all - tutte 13.450
article - articoli 12.325
book - libri 0
conference - conferenze 565
curatela - curatele 0
other - altro 356
patent - brevetti 0
selected - selezionate 0
volume - volumi 204
Totale 26.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 7 20
2019/2020611 62 10 8 40 50 63 69 26 26 66 48 143
2020/2021618 129 90 27 77 79 50 9 37 24 19 52 25
2021/2022716 51 242 116 29 25 11 10 36 22 21 34 119
2022/20231.071 76 131 87 191 93 243 20 53 122 6 29 20
2023/2024378 21 40 37 60 40 92 16 45 3 23 1 0
Totale 4.575